ERC/mesothelin as a marker for chemotherapeutic response in patients with mesothelioma.
Tajima K, Hirama M, Shiomi K, Ishiwata T, Yoshioka M, Iwase A, Iwakami S, Yamazaki M, Toba M, Tobino K, Sugano K, Ichikawa M, Hagiwara Y, Takahashi K, Hino O.
Tajima K, et al.
Anticancer Res. 2008 Nov-Dec;28(6B):3933-6.
Anticancer Res. 2008.
PMID: 19192652
Free article.